Ashish Kumar Kakkar

2.8k total citations
72 papers, 976 citations indexed

About

Ashish Kumar Kakkar is a scholar working on Surgery, Ophthalmology and Economics and Econometrics. According to data from OpenAlex, Ashish Kumar Kakkar has authored 72 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Ophthalmology and 10 papers in Economics and Econometrics. Recurrent topics in Ashish Kumar Kakkar's work include Antibiotic Use and Resistance (9 papers), Pharmaceutical Economics and Policy (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Ashish Kumar Kakkar is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Pharmaceutical Economics and Policy (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Ashish Kumar Kakkar collaborates with scholars based in India, United Kingdom and South Africa. Ashish Kumar Kakkar's co-authors include Neha Dahiya, Tanica Lyngdoh, Rubina Mulchandani, Harmanjit Singh, Yogendra Kumar Gupta, Harmeet Singh Rehan, Ritesh Agarwal, Gurpreet Singh, Pallab Ray and Vikas Gautam and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Ashish Kumar Kakkar

68 papers receiving 943 citations

Peers

Countries citing papers authored by Ashish Kumar Kakkar

Since Specialization

Citations

This map shows the geographic impact of Ashish Kumar Kakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashish Kumar Kakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashish Kumar Kakkar more than expected).

Fields of papers citing papers by Ashish Kumar Kakkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashish Kumar Kakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashish Kumar Kakkar. The network helps show where Ashish Kumar Kakkar may publish in the future.

Co-authorship network of co-authors of Ashish Kumar Kakkar

This figure shows the co-authorship network connecting the top 25 collaborators of Ashish Kumar Kakkar. A scholar is included among the top collaborators of Ashish Kumar Kakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashish Kumar Kakkar. Ashish Kumar Kakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining drug resistance beyond rifampicin: use of Xpert® MTB/XDR assay in tuberculous meningitis 2025 ·Indian Journal of Medical Microbiology ·Kusum Sharma, Megha Sharma, (unknown), Himanshu Joshi, (unknown), Ashish Kumar Kakkar, (unknown), (unknown), (unknown), Manoj Goyal, Aman Sharma, Navneet Sharma, Manish Modi	1
2	Neuroprotective Effects of Eugenol in Alzheimer's Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques 2025 ·Current Pharmaceutical Design ·Ashish Kumar Kakkar, Harpreet Singh, (unknown), (unknown), Arun Kumar Mishra	1
3	An assessment of treatment satisfaction, adverse effects, cost of treatment among patients with type 2 diabetes for semaglutide when compared to liraglutide: a hospital-based cross-sectional study 2025 ·Discover Public Health ·(unknown), Ashish Kumar Kakkar, (unknown), (unknown)	1
4	Multipronged interventions to reduce surgical site infections: A multicenter implementation research protocol 2025 ·PLoS ONE ·(unknown), (unknown), T S Anish, (unknown), Mahendra Pratap Singh, Ashish Kumar Kakkar, Aparna Mukherjee, Niti Mittal, Sandeep Kaushal, (unknown), Robin Kaushik, Sumaira Naeem, Jaykaran Charan, (unknown)	0
5	Field based research in the era of the pandemic in resource limited settings: challenges and lessons for the future 2024 ·Frontiers in Public Health ·Rubina Mulchandani, Tanica Lyngdoh, Sheetal Gandotra, (unknown), Rajinder K. Dhamija, Ashish Kumar Kakkar	1
6	A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages 2024 ·Clinical Microbiology and Infection ·Avaneesh Kumar Pandey, Jennifer Cohn, Vrinda Nampoothiri, U. Gadde, (unknown), Ashish Kumar Kakkar, Yogendra Kumar Gupta, Samir Malhotra, Oluchi Mbamalu, Marc Mendelson, Anne‐Grete Märtson, (unknown), Thomas Tängdén, Nusrat Shafiq, Esmita Charani	14
7	Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemotherapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade 2024 ·Current Cancer Drug Targets ·Neeru M. Sharma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ashish Kumar Kakkar, Ravimohan S. Mavuduru, Smita Pattanaik	2
8	Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF – An Open Label Randomized Clinical Trial 2023 ·Journal of Clinical and Experimental Hepatology ·(unknown), Madhumita Premkumar, (unknown), Kamal Kajal, Anand V. Kulkarni, Ajay Duseja, Radha K. Dhiman, Arka De, Nipun Verma, Sunil Taneja, Sahaj Rathi, Virendra Singh, Joy Kumar Chakma, Shiv Lal Soni, Ashish Kumar Kakkar, (unknown), Chirag Ahuja, (unknown), (unknown)	2
9	Developing a latent class analysis model to identify at-risk populations among people using medicine without prescription 2020 ·Expert Review of Clinical Pharmacology ·Praveen Kumar, Rahul Mahajan, Soundappan Kathirvel, (unknown), Ashish Kumar Kakkar, Amol Patil	4
10	Impact of ophthalmic webinars on the resident's learning experience during COVID-19 pandemic 2020 ·Indian Journal of Ophthalmology ·(unknown), (unknown), Priyanka Gupta, Ashish Kumar Kakkar, (unknown), Monika Jain, (unknown), (unknown), (unknown), Himani Gupta	7
11	Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead 2020 ·European Journal of Pharmacology ·Harmanjit Singh, (unknown), Ashish Kumar Kakkar	18
12	Malignant hypertensive retinopathy - first clinical sign in young undiagnosed hypertensives 2020 ·Ashish Kumar Kakkar	1
13	Applicability of Tanaka–Johnston, Moyers, and Bernabé and Flores–Mir Mixed Dentition Analyses in School-going Children of Sri Ganganagar City, Rajasthan (India) 2019 ·Contemporary Clinical Dentistry ·Ashish Kumar Kakkar, Kanika Verma, (unknown), (unknown), (unknown), (unknown)	2
14	Old wines in new bottles: Repurposing opportunities for Parkinson's disease 2018 ·European Journal of Pharmacology ·Ashish Kumar Kakkar, Harmanjit Singh, Bikash Medhi	19
15	The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor 2016 ·Current Clinical Pharmacology ·Harmanjit Singh, Mandeep Kaur, Ashish Kumar Kakkar, (unknown)	7
16	Management of Parkinson׳s disease: Current and future pharmacotherapy 2015 ·European Journal of Pharmacology ·Ashish Kumar Kakkar, Neha Dahiya	66
17	Endoilluminator-assisted scleral buckling: Our results 2014 ·Indian Journal of Ophthalmology ·Varun Gogia, Pradeep Venkatesh, Shikha Gupta, Ashish Kumar Kakkar, Satpal Garg	25
18	A case of frost branch angitis in pregnancy : an unusual presentation 2014 ·Nepalese Journal of Ophthalmology ·Meenakshi Wadhwani, Varun Gogia, Ashish Kumar Kakkar, (unknown), Pradeep Venkatesh, (unknown)	2
19	Resolution of Serous Retinal Detachment Following Partial Sclerectomy With Mitomycin C in Nanophthalmos 2013 ·Ophthalmic surgery, lasers & imaging retina ·Pradeep Venkatesh, (unknown), Ashish Kumar Kakkar, (unknown), Varun Gogia, Satpal Garg	3
20	Pattern of surgical antibiotic prophylaxis in a tertiary care teaching hospital in India 2010 ·International journal of infection control ·Harmeet Singh Rehan, Ashish Kumar Kakkar, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact